MIRA Pharmaceuticals Inc. (MIRA)
NASDAQ: MIRA
· Real-Time Price · USD
1.25
0.04 (3.31%)
At close: Jun 16, 2025, 3:59 PM
3.31% (1D)
| Bid | 1.2 |
| Market Cap | 21.06M |
| Revenue (ttm) | n/a |
| Net Income (ttm) | -7.92M |
| EPS (ttm) | -0.47 |
| PE Ratio (ttm) | -2.65 |
| Forward PE | -3.09 |
| Analyst | Buy |
| Ask | 1.26 |
| Volume | 77,367 |
| Avg. Volume (20D) | 1,236,409 |
| Open | 1.24 |
| Previous Close | 1.21 |
| Day's Range | 1.21 - 1.25 |
| 52-Week Range | 0.51 - 5.01 |
| Beta | 1.98 |
About MIRA
undefined
Industry n/a
Sector n/a
IPO Date n/a
Employees NaN
Stock Exchange n/a
Ticker Symbol MIRA
Website n/a
Analyst Forecast
According to 0 analyst ratings, the average rating for MIRA stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.
Stock Forecasts2 months ago
+19.26%
MIRA Pharmaceuticals shares are trading higher aft...
Unlock content with
Pro Subscription
7 months ago
+21.71%
MIRA Pharmaceutical shares are trading higher after the company's new preclinical data showed that Ketamir-2 achieved 60% greater efficacy than the FDA-approved gabapentin in reducing chemotherapy-induced pain.
